This antibody is intended for in vitro diagnostic (IVD) use.
Ventana Medical Systems’ (Ventana) CONFIRM anti-MITF (C5/D5) Mouse Monoclonal Primary Antibody is a mouse monoclonal cocktail. This antibody cocktail reagent detects microphthalmia transcription factor (MITF) proteins 52-56KD of MITF expressing cells in normal and neoplastic tissues. This antibody is used in the identification of melanotic lesions such as malignant melanoma and melanotic neurofibroma. The antibody is intended for qualitative staining in sections of formalin-fixed, paraffin-embedded tissue. The clinical interpretation of any staining or absence of staining, must be complemented by morphological studies and evaluation of proper controls. Evaluation must be made by a qualified pathologist within the context of the patient’s clinical history and other diagnostic tests.